Literature DB >> 29428775

Evaluation of the DSM-5 severity ratings for anorexia nervosa in a clinical sample.

Antonios Dakanalis1, C Alix Timko2, Fabrizia Colmegna3, Giuseppe Riva4, Massimo Clerici5.   

Abstract

We examined the validity and utility of the DSM-5 severity ratings for anorexia nervosa (AN) in a clinical (treatment-seeking) sample (N = 273; 95.6% women). Participants classified with mild, moderate, severe, and extreme severity of AN based on their measured body mass index, differed significantly from each other in eating disorder features, putative maintenance factors, and illness-specific functional impairment (medium effect sizes). However, they were statistically indistinguishable in psychiatric-disorder comorbidity and distress, demographics, and age-of-AN onset. The implications of our findings, providing limited support for the DSM-5 severity ratings for AN, and directions for future research are outlined.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Eating psychopathology; Functional impairment; Psychiatric comorbidity

Mesh:

Year:  2018        PMID: 29428775     DOI: 10.1016/j.psychres.2018.02.009

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  8 in total

1.  Prevention of eating disorders: current evidence-base for dissonance-based programmes and future directions.

Authors:  Antonios Dakanalis; Massimo Clerici; Eric Stice
Journal:  Eat Weight Disord       Date:  2019-05-30       Impact factor: 4.652

2.  Gender differences in eating disorder psychopathology across DSM-5 severity categories of anorexia nervosa and bulimia nervosa.

Authors:  Lazaro V Zayas; Shirley B Wang; Kathryn Coniglio; Kendra Becker; Helen B Murray; Eric Klosterman; Brian Kay; Pamela Bean; Theodore Weltzin; Debra L Franko; Kamryn T Eddy; Jennifer J Thomas
Journal:  Int J Eat Disord       Date:  2018-09-07       Impact factor: 4.861

3.  Embodiment as a Paradigm for Understanding and Treating SE-AN: Locating the Self in Culture.

Authors:  Connie Marguerite Musolino; Megan Warin; Peter Gilchrist
Journal:  Front Psychiatry       Date:  2020-06-12       Impact factor: 4.157

4.  Assessment of Family Functioning and Eating Disorders - The Mediating Role of Self-Esteem.

Authors:  Zdzisław Kroplewski; Małgorzata Szcześniak; Joanna Furmańska; Anita Gójska
Journal:  Front Psychol       Date:  2019-04-24

5.  Mental, behavioral and neurodevelopmental disorders in the ICD-11: an international perspective on key changes and controversies.

Authors:  Dan J Stein; Peter Szatmari; Wolfgang Gaebel; Michael Berk; Eduard Vieta; Mario Maj; Ymkje Anna de Vries; Annelieke M Roest; Peter de Jonge; Andreas Maercker; Chris R Brewin; Kathleen M Pike; Carlos M Grilo; Naomi A Fineberg; Peer Briken; Peggy T Cohen-Kettenis; Geoffrey M Reed
Journal:  BMC Med       Date:  2020-01-27       Impact factor: 8.775

Review 6.  Are poor set-shifting and central coherence associated with everyday function in anorexia nervosa? A systematic review.

Authors:  Kelly M Dann; Phillipa Hay; Stephen Touyz
Journal:  J Eat Disord       Date:  2021-03-29

7.  Age dependency of body mass index distribution in childhood and adolescent inpatients with anorexia nervosa with a focus on DSM-5 and ICD-11 weight criteria and severity specifiers.

Authors:  Judith Sinzig; Triinu Peters; Johannes Hebebrand; Christian Engelhardt; Manuel Föcker; Katharina Bühren; Brigitte Dahmen; Katja Becker; Linda Weber; Christoph U Correll; Karin Maria Egberts; Stefan Ehrlich; Veit Roessner; Christian Fleischhaker; Alexander von Gontard; Freia Hahn; Ekkehart Jenetzky; Michael Kaess; Tanja Legenbauer; Tobias J Renner; Ulrike M E Schulze; Ida Wessing; Gisela Antony; Beate Herpertz-Dahlmann
Journal:  Eur Child Adolesc Psychiatry       Date:  2020-07-14       Impact factor: 4.785

8.  Body Mass Index Specifiers in Anorexia Nervosa: Anything below the "Extreme"?

Authors:  Federica Toppino; Paola Longo; Matteo Martini; Giovanni Abbate-Daga; Enrica Marzola
Journal:  J Clin Med       Date:  2022-01-21       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.